CRESCENT BIOPHARMA, INC.

financial.report · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.

Event type

financial.report

Occurred

2025-12-31

Reported

2026-02-26

Disclosure lag

57 days

Context

links are based on the recorded entity type

Field	Recorded value
Entity	CRESCENT BIOPHARMA, INC.
Source	SEC EDGAR ↗
Source identifier	companyfacts/CIK0001253689/2026-07-26
Event ID	#27525

Recorded payload

JSON payload as stored after parsing

{
  "accession": "0001628280-26-011983",
  "canonical_covered": 11,
  "canonical_total": 12,
  "fiscal_period": "FY",
  "fiscal_year": 2025,
  "form": "10-K",
  "mapped_tag_share": 0.05128205128205128,
  "metrics": {
    "cash_and_equivalents": 213192000,
    "net_income": -153942000,
    "operating_cash_flow": -71532000,
    "operating_income": -152632000,
    "revenue": 10844000,
    "shareholders_equity": 203012000,
    "shares_outstanding": 27556767,
    "total_assets": 240293000,
    "total_liabilities": 37281000
  },
  "metrics_reported": 9,
  "period_end": "2025-12-31"
}

Source: SEC EDGAR · as of 2026-02-26T00:00:00Z